Why are athletes calling for increased ME funding?
More than 350 prominent sporting figures are demanding that the Prime Minister prioritize research into myalgic encephalomyelitis (ME) to address a massive disparity in medical investment. The letter, which has garnered support from high-profile names such as Everton manager David Moyes and US women's football coach Emma Hayes, calls for the government to "level the playing field" regarding research allocations. The core of the argument rests on the fact that ME currently receives significantly less financial backing than other major neurological and chronic conditions.
The discrepancy in research spending is stark when comparing recent government commitments. According to the data cited in the letter, between 2019 and 2024, UK government research funders allocated just £6.6m to ME. In contrast, Parkinson's disease received £79.1m, and dementia research saw an investment of £496.4m during the same period. Advocates argue that this lack of financial support has directly contributed to the absence of approved, specific treatments for the disease.
The scale of the research gap
The advocacy group, supported by 114 Olympians and Paralympians including Laura Muir and Adam Gemili, emphasizes that the current level of investment is insufficient to tackle a disease that affects a massive portion of the population. Karen Hargrave, co-founder of the charity ThereForME, has identified a specific £15m funding gap for Sequence ME & Long Covid. Closing this gap is viewed as a vital first step toward placing ME research on an equal footing with other life-altering illnesses.
How does ME impact the lives of those diagnosed?
Myalgic encephalomyelitis is a chronic, fluctuating disease characterized by severe, persistent fatigue that does not improve with rest and can cause over 200 different symptoms. For many patients, the condition is "life-decimating," leading to extreme physical limitations. Former sprinter Beth Dobbin, who recently shared her diagnosis with BBC Sport, reported spending more than 22 hours a day in bed due to the severity of her symptoms.
The disease manifests through a wide array of debilitating issues, including:
- Severe cognitive dysfunction, often referred to as "brain fog."
- Persistent sleep disturbances and memory problems.
- Chronic pain and nausea.
- Extreme sensitivity to external stimuli, such as bright lights or loud sounds.
A defining feature of ME is the risk of a "crash" following physical or mental exertion. Even minor activities—such as holding a conversation or managing sensory input—can trigger a sudden deterioration in health that may last from 48 hours to several months. For Dobbin, the process of speaking out about her condition carries the inherent risk of triggering such a brutal physical decline.
What is the current scale of the ME epidemic?
Estimates regarding the number of people living with ME vary significantly, but the scale of the impact is undeniably vast. In the UK alone, it is thought that more than 400,000 people are living with the condition. However, some estimates suggest the true figure could actually exceed one million individuals.
The severity of the illness creates a broad spectrum of patient needs. While some individuals are able to maintain employment or continue their studies, others face much more extreme circumstances. A significant portion of the patient community requires round-the-clock care and may rely on tube feeding to maintain nutrition. This wide range of disability underscores the need for more robust research into both the biological causes and the practical management of the disease.
What has the government's response been to these pleas?
While the Prime Minister has not yet responded to Beth Dobbin's initial letter sent on October 21, the Department of Health and Social Care has expressed a commitment to improving the understanding of the condition. Government spokespeople have stated that they are determined to accelerate progress in treating this debilitating illness and are supporting various research initiatives.
Current government-backed efforts include:
- A first-of-its-kind programme focusing on the genetic factors associated with ME.
- Clinical trials aimed at identifying potential new treatments.
- A strategic plan developed in collaboration with the ME community to boost awareness and support.
Despite these stated commitments, advocates argue that the historical lack of biomedical research funding has left the community neglected. The current push by the sporting community is intended to move beyond general support and into the realm of significant, comparable financial investment that can drive clinical breakthroughs.
Frequently asked questions
What is the main difference between ME and general fatigue?
Unlike standard tiredness, ME involves severe, persistent fatigue that is not relieved by sleep or rest. It is often accompanied by cognitive issues, pain, and a specific phenomenon where minor exertion causes a significant, long-lasting physical "crash" that can disable a person for days or months.
How much funding is being requested by advocates?
Advocates, including representatives from the charity ThereForME, are highlighting a £15m funding gap specifically for Sequence ME & Long Covid. The broader goal is to increase ME research funding to levels comparable to other major diseases like Parkinson's or dementia.
Who is leading the advocacy for ME research?
The movement is currently led by former sprinter Beth Dobbin, whose personal diagnosis and subsequent interview have brought international attention to the disease. She is supported by over 350 sportspeople and various medical charities seeking government intervention.
Can ME be treated with current medical advancements?
Currently, there are no approved, specific treatments or a known cure for ME. Patients often rely on off-label medications to manage individual symptoms, such as pain or nausea, rather than treating the underlying cause of the disease.
Why are athletes involved in this health issue?
Athletes like Dobbin have experienced firsthand how ME can abruptly end professional careers and physical capabilities. Their involvement aims to use their public platforms to highlight the neglect of the condition and pressure policymakers to provide necessary research resources.
Key takeaways
- Over 350 athletes are calling for increased ME research funding from the UK government.
- ME research received only £6.6m between 2019 and 2024, far less than Parkinson's or dementia.
- Beth Dobbin, a former sprinter, is a central figure in the plea for better medical support.
- The disease can cause patients to be bedbound for up to 22 hours a day.
The path toward medical recognition
The intersection of elite athletics and chronic illness advocacy has brought a unique visibility to the struggles of the ME community. By leveraging the influence of Olympians and global sporting figures, advocates are attempting to transform a historically neglected medical issue into a high-priority political agenda. While the government has pledged support through genetic research and clinical trials, the significant disparity in historical funding remains a major hurdle. The success of this movement will likely depend on whether the Prime Minister responds to the call for a meeting and commits to closing the substantial funding gap that currently separates ME research from other major neurological conditions.
